Cargando…

Drug‐induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis

A 69‐year‐old woman was diagnosed with a breakpoint cluster region‐Abelson‐positive chronic myeloid leukaemia and treated with dasatinib for 14 months. She presented with one month of high‐grade fever and persistent dry cough. Chest computed tomography revealed non‐segmental subpleural consolidation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tani, Nozomi, Kunimatsu, Yusuke, Sato, Izumi, Ogura, Yuri, Hirose, Kazuki, Takeda, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450224/ https://www.ncbi.nlm.nih.gov/pubmed/32874590 http://dx.doi.org/10.1002/rcr2.654

Ejemplares similares

IgG4‐related lung disease progressing to respiratory failure
por: Kunimatsu, Yusuke, et al.
Publicado: (2020)

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
por: Kataoka, Nobutaka, et al.
Publicado: (2020)

Vogt–Koyanagi–Harada disease during chemoimmunotherapy for non‐small cell lung cancer
por: Kurono, Yuri, et al.
Publicado: (2020)

Predictors of survival among Japanese patients receiving first‐line chemoimmunotherapy for advanced non‐small cell lung cancer
por: Ogura, Yuri, et al.
Publicado: (2020)

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation—A Case Report and a Review of the Literature
por: Sato, Izumi, et al.
Publicado: (2020)

Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study
por: Tani, Nozomi, et al.
Publicado: (2021)

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis
por: Takeda, Takayuki, et al.
Publicado: (2020)

Entrectinib for ROS1‐rearranged non‐small cell lung cancer after crizotinib‐induced interstitial lung disease: A case report
por: Tanimura, Mai, et al.
Publicado: (2021)

Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report
por: Kataoka, Nobutaka, et al.
Publicado: (2021)

Mycobacterium tuberculosis Infection in the Setting of Interstitial Lung Disease: Coincidence or Bad Luck?
por: Wong, Christian, et al.
Publicado: (2018)

Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib
por: Takekoshi, Daisuke, et al.
Publicado: (2020)

Pseudoprogression during induction treatment with nivolumab plus ipilimumab combined with chemotherapy for metastatic lung adenocarcinoma: A case report
por: Kunimatsu, Yusuke, et al.
Publicado: (2023)

Atezolizumab in combination with carboplatin plus nab‐paclitaxel for managing combined large‐cell neuroendocrine carcinoma: A case report
por: Tsutsumi, Rei, et al.
Publicado: (2022)

Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report
por: Kano, Yukari, et al.
Publicado: (2022)

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
por: Martyanov, Viktor, et al.
Publicado: (2017)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

Interstitial lung disease with usual interstitial pneumonia pattern preceding the presentation of ANCA-associated vasculitis by 4 years: coincidence or correlation?
por: Kishore, Nevin, et al.
Publicado: (2018)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

Dasatinib suppresses particulate-induced pyroptosis and acute lung inflammation
por: Pan, Yixi, et al.
Publicado: (2023)

Interstitial Lung Diseases Misdiagnosed as Tuberculosis
por: Akhter, Nousheen, et al.
Publicado: (2018)

Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
por: Tabata, Mitsuki, et al.
Publicado: (2020)

Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer
por: Gordian, Edna, et al.
Publicado: (2014)

Drug Induced Interstitial Lung Disease
por: Schwaiblmair, Martin, et al.
Publicado: (2012)

Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)

Dasatinib Nanoemulsion and Nanocrystal for Enhanced Oral Drug Delivery
por: Wang, Chuanqi, et al.
Publicado: (2022)

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
por: Yamaya, Takafumi, et al.
Publicado: (2022)

A Case of Disseminated Cryptococcal Infection and Concurrent Lung Tuberculosis in a Patient under Steroid Therapy for Interstitial Pneumonia
por: Kuroda, Aoi, et al.
Publicado: (2015)

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
por: Toya, Takumi, et al.
Publicado: (2019)

Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked
por: Dayal, Seema
Publicado: (2017)

Dasatinib-Related Chylothorax
por: Huang, Yen-Min, et al.
Publicado: (2015)

DASATINIB-RELATED CHYLOTHORAX
por: Young, Katherine, et al.
Publicado: (2019)

Reversible ventricular arrythmia induced by dasatinib
por: Spechbach, Hervé, et al.
Publicado: (2013)

Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020)

Dasatinib induced pleuro-pericardial effusion
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
por: Li, Jiannong, et al.
Publicado: (2010)

Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
por: Cruz, Fernanda Ferreira, et al.
Publicado: (2016)

A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
por: Nekoukar, Zahra, et al.
Publicado: (2021)

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
por: Sato, Shinji, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3u552a4jbp50jd9h13hd3lk9bm